When comparing HOXA11 methylation level to clinical features, we noticed a significant higher incidence of hypermethylation in invasive ductal carcinomas (IDCs), patients with a family history of cancer, cases with metastatic lymph nodes and P53 positive group than their counterparts. This evidence concerns the gene HOXA11 and invasive ductal breast carcinoma.